Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma (AI)

Sun Yat-sen University

Status: Unknown

Conditions: Ophthalmopathy

Treatments: Device: CASIA 2 OCT

Study type: Observational

Funder types: Other

Identifiers

NCT03611387

CCPMOH2018-China-4

Details and patient eligibility

About

The Tomey CASIA (Tomey Corporation, Nagoya, Japan) is a novel rapid imaging device that captures high-quality imaging of the entire anterior chamber of the eye over detailed imaging of a single section. In this prospective study, we want to investigate and compare the anatomical structure of the drainage angle of the eye in patients with different types glaucoma using Tomey machine. This study gives us a better understanding of the predictability, validity and accuracy of Tomey machine in the diagnosis of different types of glaucoma. Moreover, the data collected here will be used to create an artificial intelligence (AI) platform to screen certain type of glaucoma.

Full description

Patients ≥18 years old from ophthalmic clinics with or without glaucoma were enrolled to this respective observational clinical study. However, patients with any history of eye surgery (except cataract surgery) including laser procedure were excluded. The investigators will review patients' medical chart and update any medical history in your medical record. If new scans are needed, investigators will do them at the time of patients' current visit and it will require about 30 mins. CASIA SS-OCT (CASIA 2) is a non-contact scan of the front of the eye with higher resolution and provides deeper, wider and three- dimensional views. It is the newest scan machine. It is not FDA-approved but is approved in many other countries including Japan for patient use. We may perform the scan in the light and dark condition. We may also perform the routine scan to capture images of the anterior part of the eye for comparison purpose. The results of the scanned data will be among patients' medical records. Age, sex and ethnicity within your medical records will also be used for the analysis.

Enrollment: 1,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patient with or without glaucoma

Exclusion criteria

• Patients with any history of eye surgery (except cataract surgery) including laser procedure.
• Age < =18 years

Trial design

1,500 participants in 3 patient groups

Normal

Description:

Patients without any type of glaucoma

Treatment:

Device: CASIA 2 OCT

Primary angle closure glaucoma

Description:

Patients with primary angle closure glaucoma

Treatment:

Device: CASIA 2 OCT

Primary open-angle glaucoma

Description:

Patients with primary open-angle glaucoma

Treatment:

Device: CASIA 2 OCT